New dengue shot formula put to the test in Final-Stage trial
NCT ID NCT07047521
Summary
This study is testing if a new version of an existing dengue vaccine works as well as the current version. About 500 healthy adults who have never had dengue will receive two shots, three months apart, of either the new or current formula. Researchers will check the participants' blood to see if their immune response is similar and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emeritus Research Camberwell (Melbourne)
Camberwell, Victoria, 3124, Australia
-
Emeritus Research Sydney
Botany, New South Wales, 2019, Australia
-
Paratus Clinical Research Central Coast
Kanwal, New South Wales, 2259, Australia
-
Paratus Clinical Research Western Sydney
Blacktown, New South Wales, 2150, Australia
-
Veritus Research
Bayswater, Victoria, 3153, Australia
Conditions
Explore the condition pages connected to this study.